newsfilter
← Latest News
Business Wire·

TissueTech Expands its Clinical Program with Medidata’s End-to-end Unified Platform

NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) announced that TissueTech, Inc. has chosen the Medidata Rave Clinical Cloud™ as its end-to-end platform for clinical trials. TissueTech recognizes this partnership as critical to helping spearhead the company’s transformation in biologics with a focus on regenerative therapies derived from human birth tissue for patients with serious unmet clinical needs.